Prawo i regulacje · 02/06/2021

DEA Places Remimazolam in Schedule IV of Controlled Substances Act

The US Drug Enforcement Administration (DEA) has finalized a rule placing the sedative remimazolam in Schedule IV of the Controlled Substances Act, following an interim rule published in 2020.